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gressed patients (1.3, p = 0.005). A multivariate regression 
analysis showed higher mean, peak and variance of IOP, 
number of glaucoma medications at the final visit and pres-
ence of a disc hemorrhage (n = 5) as independent risk factors 
for progression (p  ^  0.05).  Conclusion: IOP reduction in XFG 
may be essential in reducing disease progression. The pres-
ence of disc hemorrhage in XFG may suggest an increased 
probability of progression despite treatment to within the 
normal IOP range.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Exfoliative glaucoma is the most common type of sec-
ondary open-angle glaucoma  [1] . Compared to primary 
open-angle glaucoma, it is frequently a more severe and 
more rapidly progressing disease  [1–4] . Most authors 
have found that untreated intraocular pressure is higher 
in exfoliative glaucoma than in primary open-angle glau-
coma  [5–10] . Further, exfoliative glaucoma may be asso-
ciated with greater visual field loss as well as more rapid 
progression of visual field and optic nerve damage than 
primary open-angle glaucoma  [1, 2, 11] . Accordingly, 
treatment of exfoliative glaucoma may be more difficult 
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 Abstract 
 Purpose: To evaluate exfoliative glaucoma (XFG) patients 
over 5 years, determining risk factors associated with pro-
gression or non-progression of glaucoma.  Methods: A retro-
spective, observational study. Patients were chosen from 
consecutive charts and data collected from each available 
visit included in the follow-up period. Data were abstracted 
for non-progressed XFG patients for 5 years and for pro-
gressed patients until glaucoma worsened. Progression was 
determined from patient records and by disc photographs. 
 Results: There were 71 (53%) progressed and 63 (47%) non-
progressed XFG patients.  Baseline parameters demonstrat-
ed worse visual field damage (p = 0.014) and more prescribed 
medicines (p = 0.03) in progressed patients. The mean intra-
ocular pressure (IOP) for progressed patients was 18.7  8 4.3 
and 17.3  8 3.4 mm Hg for non-progressed patients (p = 
0.047). The mean IOP that best separated the groups was 17 
mm Hg with 60% staying non-progressed at or below this 
level and 30% above this level. At the last visit, progressed 
patients had more medicines prescribed (1.7) than non-pro-
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with a higher incidence of therapeutic failure, requiring 
more aggressive therapy, than primary open-angle glau-
coma  [4, 12–14] .
 Unfortunately, data on exfoliative glaucoma patients’ 
treatment endpoints that would help to prevent their 
glaucomatous progression are limited. In 2004, Konstas 
et al.  [15] suggested that in exfoliative glaucoma patients 
the long-term mean intraocular pressure which best pre-
vented progression was  ^  17 mm Hg. However, some pa-
tients progressed despite lowering the pressure to  ^  17 
mm Hg. Consequently, other risk factors for progression 
may exist in certain exfoliative glaucoma patients who, to 
date, have not been identified.
 Recently, Holló et al.  [16] evaluated the presence of car-
diovascular disease as a potential risk factor for progres-
sion of exfoliative glaucoma. Although the results were 
not conclusive, the study suggested that patients with a 
history of cardiovascular disease might require a slightly 
lower target intraocular pressure to prevent progression 
(18 mm Hg) than those without (20 mm Hg). This find-
ing also suggests that additional, probably vascular risk 
factors of progression in exfoliative glaucoma need to be 
identified.
 The purpose of the current study was to determine 
risk factors associated with progression or non-progres-
sion of exfoliative glaucoma using clinical data registered 
during a 5-year follow-up period.
 Patients and Methods 
 Patients 
 The trial was performed in five centers across Europe in Hun-
gary, Italy, Slovenia, Russia and Spain. The study design was a 
retrospective, observational study of a single cohort. Since this 
was a retrospective analysis requiring no patient identifiers, an 
ethics committee approval was not required at any of the partici-
pating research centers.
 We included in this study patients with: a minimum of 5 
years of records with a diagnosis of non-progressed or pro-
gressed exfoliative glaucoma (based on typical anterior segment 
findings of exfoliation syndrome, glaucomatous optic disc and/
or nerve fiber layer changes, and/or glaucomatous visual field 
defect). Glaucomatous optic nerve head changes were character-
ized with neuroretinal rim thinning or notching, saucerization, 
thin nasal rim or total cupping. Visual field changes typical for 
glaucoma comprised nasal step or paracentral, Seidel’s or arcu-
ate scotoma. Included patients had to have at least seven visits 
with a documented intraocular pressure value and at least three 
sets of documented disc examinations (photographs, detailed 
disc drawings or HRT analyses) recorded during the 5-year fol-
low-up period within  8 12 months of the first and final visits, 
respectively. Patients must have demonstrated typical anteri-
or chamber findings of exfoliation syndrome including: exfolia-
tion material deposits on the lens surface, Sampaolesi’s line with 
irregular trabecular meshwork pigmentation by gonioscopy, 
moth-eaten pupillary margin and iris transillumination defects 
at the sphincter area  [15] .
 We excluded patients from this study who had progressive 
non-glaucomatous visual loss; refractive surgery in the study eye 
before or during the study period; any abnormality that prevented 
reliable applanation tonometry; intraocular conventional or laser 
surgery less than 3 months prior to the first abstracted visit; media 
opacity preventing reliable optic nerve head or visual field evalu-
ation at the first and last abstracted visit; primary, acute or chron-
ic angle closure; secondary as well as congenital glaucoma; known 
occludable angles by gonioscopy or presence of any other clini-
cally significant angle abnormalities, or who had been enrolled in 
a prospective clinical trial during the follow-up period.
 Procedures 
 Patients were chosen from consecutive charts from the prac-
tices of the study investigators and reviewed alphabetically. Data 
collections began from the patient’s initial examination by the 
investigator and were recorded from each available visit included 
in the follow-up period. Data were abstracted for non-progressed 
exfoliative glaucoma patients for 5 years. In contrast, data were 
abstracted for progressed exfoliative glaucoma patients until the 
time the glaucoma worsened. Data were not abstracted after the 
time of progression so the information included in this study 
would reflect the ocular condition that worsened the glaucoma.
 Data recorded from each visit included: intraocular pressure 
determined using Goldmann applanation tonometry, glaucoma 
therapeutic procedures, date of visits, dilated optic disc and vi-
sual field examinations. The same investigator supervised each 
patient during the follow-up period. The patient’s ophthalmic and 
limited systemic medical history (cardiovascular, systemic hy-
pertension, diabetes, and dyslipidemia), pachymetry and demo-
graphics were collected at the first visit. Data on ophthalmic med-
ication, cup/disc ratio, best corrected visual acuity and the visual 
field results were collected both at the first and last visits.
 Progression was determined from the investigator’s clinical 
notations in the patients’ records. In each case progression was 
noted in the chart with the associated reason. Generally, criteria 
for progression were an increase in thinning of the neuroretinal 
rim or a reproducible worsening of glaucomatous visual field loss. 
In patients with total glaucomatous cupping and diffusely de-
pressed visual fields, worsening of the best corrected visual acuity 
could also be used as the last any only measurable sign of progres-
sion. Patients without ‘progression’ noted were assumed non-pro-
gressed.
 Statistics 
 PRN Pharmaceutical Research Network, LLC, analyzed the 
data. If both eyes of a patient met the criteria for entrance into the 
study, one eye was randomly chosen to be analyzed. All analyses 
were two sided and unpaired. A value of 0.05 was selected to de-
terminate statistical significance.
 An ANOVA test was used to analyze data for: age, mean and 
peak intraocular pressures, number of office visits, the number of 
medicines prescribed at baseline and at the end of the study fol-
low-up period, the study term in years, baseline pachymetry, cup/
disc ratio, visual acuity, the number of laser trabeculoplasties and 
trabeculectomies, and systemic history  [17, 18] . The F test was 
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used to analyze the difference in the variance (the square of the 
standard deviation) of the individual patient’s intraocular pres-
sures measured during the follow-up period, between progressed 
and non-progressed patients  [17] .
 A   2 or Fisher’s exact test was used to analyze differences in 
non-ordered scores such as: visual field diagnoses, left or right 
eye, gender, and the incidence of disc hemorrhage  [17, 19] . The 
target for the intraocular pressure which best prevented glauco-
matous progression was determined and described, but was not 
analyzed statistically. Risk factors for glaucomatous progression 
were also analyzed by a multivariate regression analysis.
 Results 
 Baseline Measures 
 We included 134 exfoliative glaucoma patients in this 
study of whom 71 (53%) were progressed and 63 (47%) 
non-progressed.  Table 1 shows the baseline characteris-
tics of patients who were progressed and non-progressed 
over the 5-year follow-up period. At baseline, there was 
no statistical difference between groups for any clinical 
or historical parameter except for a greater number of 
glaucoma medicines (p = 0.03) and more visual field 
damage (p = 0.014) in patients who later progressed.
Table 1. B aseline patient characteristics (mean 8 SD value or number of patients)
Characteristics Detail Progressed Non-progressed p value
Patients 71 63
Age, years 69.988.2 68.088.1 0.17
Glaucoma medicines, n 1.380.9 1.080.7 0.03
Visual acuity 0.880.3 0.980.3 0.24
Pachymetry, m 535.2830.9 544.8831.0 0.10
Cup/disc ratio Vertical 0.680.3 0.680.2 0.33
Horizontal 0.680.3 0.580.3 0.09
Systemic history Cardiovascular history 9 11 0.44
Systemic hypertension 28 27 0.69
Diabetes 6 4 0.64
Dyslipidemia 2 3 0.55
Study eye Right 40 27 0.12
Left 31 36
Gender Male 31 34 0.23
Female 40 29
Visual field diagnoses Normal 19 32 0.014
Abnormal – glaucoma 42 24
Abnormal – other 4 2
T he bold line divides the characteristics of the statistical test used: above the bold line a one-way ANOVA 
test and below a 2 or Fisher’s exact test.
Table 2. F ollow-up measures (mean 8 SD value or number of
patients)
Follow-up measures Pro-
gressed
Non-
progressed 
p
value
Patients 71 63
Office visits, n 7.584.7 9.085.3 0.07
Glaucoma medicines, n 1.780.9 1.380.8 0.005
Study term, years 3.482.1 5.380.5 <0.001
Laser trabeculoplasty 0.180.3 0.080.2 0.24
Trabeculectomy 0.180.4 0.280.4 0.47
Mean intraocular pressure 18.784.3 17.383.4 0.047
Peak intraocular pressure 25.087.1 25.186.9 0.96
Presence of disc hemorrhage
Yes 5 0 0.06
No 66 63
Variance of intraocular pressure 24.5 19.7 <0.001
T he bold lines divide the characteristics by the statistical test 
used: the top group using one-way ANOVA test, the middle 2 or 
Fisher’s exact test, and the bottom F-test.
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 Follow-Up Parameters 
 The clinical follow-up parameters are presented in  ta-
ble 2 . Progressed patients, as expected by the trial design 
of the study, had a shorter follow-up time (p  ! 0.001). At 
the last visit, progressed patients also had more medicines 
prescribed (p = 0.005) as well as over the follow-up period 
a higher mean intraocular pressure (p = 0.047) and mean 
variance of the pressure (p  ! 0.001).
 Figure 1 shows the number of patients who progressed 
or were non-progressed at each mean pressure. The mean 
pressure which best separated non-progressed from pro-
gressed patients was 17 mm Hg with 60% (45/75) staying 
non-progressed below this level and 40% (30/75) pro-
gressed. Above this level, 30% (18/59) remained non-pro-
gressed and 70% (41/59) progressed.
 Regression Analysis 
 The results of the multivariate regression analysis are 
shown in  table 3 . The mean, peak and variance of intra-
ocular pressure, the number of glaucoma medications at 
the final visit and the presence of a disc hemorrhage were 
the only independent risk factors for progression (p  ^  
0.05).
 Discussion 
 The purpose of the current study was to determine 
risk factors associated with progression or non-progres-
sion of exfoliative glaucoma using clinical data registered 
during a 5-year follow-up period.
Table 3. R isk factors for progression by multivariate regression 
analysis
Risk factors p value
Disc hemorrhage 0.05
Age 0.94
Systemic history 0.59
Gender 0.14
Mean intraocular pressure 0.003
Peak intraocular pressure 0.002
Variance of intraocular pressure 0.01
Glaucoma medications at baseline 0.35
Glaucoma medications at final visit 0.02
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 Fig. 1. The number of patients who progressed or were non-progressed at each mean intraocular pressure. 
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 In the current study we found that 53% of our exfolia-
tive glaucoma patients under treatment progressed based 
on structural and/or functional findings over a 5-year 
follow-up period. The mean variance of the pressure was 
statistically higher in progressed (24.5 mm Hg) than in 
non-progressed patients (19.7 mm Hg). A higher variance 
was also previously found as a risk factor for progression 
in exfoliative patients by Konstas et al.  [15] .
 This study also found that the mean pressure was sta-
tistically higher in progressed (18.7 mm Hg) than in non-
progressed patients (17.3 mm Hg). The mean pressure 
which best separated non-progressed from progressed 
patients was approximately  ^  17 mm Hg. At or below 
this cut-off value, 60% of the exfoliative glaucoma eyes 
did not show progression, while at higher mean intra-
ocular pressure values only 30% of the eyes remained 
non-progressed. This finding is consistent with the re-
sults of earlier studies by Konstas et al.  [15] as well as 
Holló et al.  [16] that in exfoliative glaucoma patients the 
pressure level that best separated progression and non-
progression over 5 years was approximately 17 mm Hg. 
In addition, this pressure level is similar to that found for 
primary open-angle glaucoma in a number, but not all 
studies  [20–24] .
 Further, in several previous investigations it has been 
shown that the mean intraocular pressure is an indepen-
dent risk factor for progression both in exfoliative glau-
coma and primary open-angle glaucoma by multivariate 
regression analysis  [15, 23, 25–29] . In the current study, 
again the mean pressure, as well as the peak and variance 
of the pressure, were identified statistically as risk factors 
for progression. Nonetheless, despite the intraocular 
pressure control achieved in our current study to  ^  17 
mm Hg, similarly to previously published results, 40% of 
the exfoliative glaucoma eyes still progressed  [15] . This 
number is generally higher than the number reported for 
primary open-angle glaucoma at similar intraocular 
pressure levels  [20–25] .
 The reason that some patients progressed even with a 
reduced intraocular pressure has not been clarified. Since 
in exfoliative glaucoma cardiovascular regulation has 
been shown to be altered and damaged, it has been pro-
posed that patients progressing despite well-controlled 
pressure may have resulted from a compromised cardio-
vascular system  [30–35] . Nonetheless, although many of 
our patients had a history of cardiovascular disease, the 
incidence was similar between progressed and non-pro-
gressed patients.
 However, all disc hemorrhages in our study were 
found in the group of progressed patients. A multivariate 
regression analysis demonstrated that disc hemorrhage 
was a risk factor for progression of exfoliative glaucoma 
in our study. Bengtsson et al.  [25] recently noted in a 
mixed primary open-angle/exfoliative glaucoma popu-
lation from data obtained in the Early Manifest Glau-
coma Trial, that the occurrence of a disc hemorrhage was 
independent of intraocular pressure achieved with treat-
ment. In exfoliative glaucoma, as in primary open-angle 
glaucoma, a disc hemorrhage is considered to portend 
glaucomatous progression  [34–37] . Although the num-
ber of patients with disc hemorrhage in our study was 
small (n = 5), our results may indicate an increased risk 
for progressive glaucomatous damage in the presence of 
this finding  [26, 36] .
 In addition, at baseline, our progressed patients dem-
onstrated more advanced glaucomatous damage and an 
increased need for medication at baseline, as compared 
to the non-progressed patients. Thus, their more ad-
vanced disease may have predisposed the progressed 
group towards further damage during follow-up, despite 
effective intraocular pressure reduction.
 Our results suggest that intraocular pressure reduc-
tion in exfoliative glaucoma both with and without disc 
hemorrhage is essential to reduce disease progression. 
However, the presence of a disc hemorrhage in exfoliative 
glaucoma may indicate an increased probability of pro-
gression despite treatment to within the normal intra-
ocular pressure range.
 The clinical importance of our data may be that exfo-
liative glaucoma patients should be followed carefully be-
cause of the high likelihood of progression despite an in-
traocular pressure level within the normal pressure 
range, under treatment. Further, the presence of a disc 
hemorrhage may suggest an increased risk for progres-
sion in exfoliative glaucoma, and may indicate a need for 
more intensive patient control and more aggressive intra-
ocular pressure reduction. Nonetheless, prospective in-
vestigations are necessary to clarify the exact role of optic 
nerve head hemorrhages in the progression of exfoliative 
glaucoma under effective intraocular pressure-lowering 
treatment to long-term mean intraocular pressure  ! 17 
mm Hg.
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